Clinical Trial Update: Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluated the combination of etanercept and gemcitabine in patients with advanced, chemotherapy-naive pancreatic adenocarcinoma; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• ENBREL (etanercept)
• Gemzar (gemcitabine)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Pancreatic Neoplasms, Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-08-14